Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Devopharma ApS
APS
Active
Advertising protection
CVR 38968254
Strandvejen 301, 2920
Charlottenlund
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Devopharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-3
-3
-3
-3
-3
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-3
-3
-3
-3
-3
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-3
-3
-3
-3
-3
Net financials
0
0
0
0
0
Profit before tax
-3
-3
-3
-3
-3
Tax
-0
-0
-0
-0
-0
Net profit
-3
-3
-3
-3
-3
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
100
100
100
100
100
Equity
41
38
34
31
28
Long-term debt
0
0
0
0
0
Short-term debt
59
63
66
69
72
Total debt
59
63
66
69
72
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-312500.0%
This company
2020
2024
Equity ratio
28.1%
This company
38.2%
Market median
-26% vs market
2020
2024
Return on equity
-11.1%
This company
18.4%
Market median
-160% vs market
2020
2024
Net profit margin (of gross profit)
-312500.0%
This company
2020
2024
Asset turnover (of gross profit)
-0.03×
This company
2020
2024
Debt / equity
2.56×
This company
0.62×
Market median
-313% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Devopharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
